Digital Follow-up Program After Discharge Home Following Thoracic Surgery
Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Jun 25, 2025
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is testing a digital follow-up program to see if it can help patients manage pain better and improve their quality of life during the first 28 days after they go home following chest surgery. Instead of the usual follow-up care, patients will use a smartphone or computer to answer questions and receive support through this program. The study aims to find out if this digital approach makes recovery easier and more comfortable after surgery.
People who might take part are adults (18 years or older) who have had chest surgery at the University Hospital Basel, stayed in the hospital for more than three nights, and speak German or French. Participants or a family member living with them should be comfortable using a smartphone or computer to complete online questionnaires. The study does not include patients who are already on certain strong medications before surgery, have serious psychological conditions, or had other major injuries. If eligible, participants can expect to be involved shortly after leaving the hospital, using the digital program to track their recovery and pain levels from home.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients who have signed an informed consent form and underwent a surgery performed at the Thoracic Surgery Department of the University Hospital Basel
- • Age ≥ 18 years at the time of informed consent
- • First participation in the Study
- • Patient operated under general anesthesia
- • Patients who are in possession of a smart phone or personal computer and have an e-mail account and are able to answer a digital questionnaire. Or an immediate caretaker in the same household owns a smartphone or personal computer and is familiar with the use
- • Patients who understand verbal and written German or French
- • Patients discharged at home after surgery
- • Hospital stay \> 3 nights after surgery
- Exclusion Criteria:
- • Patients under preoperative opioid/cortisone therapy
- • Patients who are unable to follow the procedure of the study, e. g. read or understand German or French, psychological disorders, dementia, etc.
- • Enrolment of the investigator, his/her family members, employees and other dependent person
- • Patients with polytrauma or who underwent mediastinoscopy
About University Hospital, Basel, Switzerland
The University Hospital Basel, Switzerland, is a leading academic medical center renowned for its commitment to cutting-edge research and innovative patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and therapeutic options across various disciplines. With a collaborative approach that integrates clinical practice and scientific inquiry, the University Hospital Basel fosters an environment conducive to rigorous clinical trials, ensuring the highest standards of safety and efficacy. Its strategic focus on patient-centered research aims to translate scientific discoveries into tangible health solutions, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Basel, , Switzerland
Patients applied
Trial Officials
Didier Lardinois, Prof. MD
Study Chair
University Hospital, Basel, Switzerland
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported